Progress in experimental phenylketonuria: a critical review.

Area of Science:

• Biochemistry
• Pharmacology
• Genetics

Background:

• Phenylketonuria (PKU) is a genetic disorder requiring accurate and useful experimental models for research.
• Previous research has been hampered by the use of inadequate models, limiting progress in understanding PKU pathophysiology.
• A critical review of experimental models over the last 15 years is essential for guiding future PKU research.

Purpose of the Study:

• To review experimental progress in developing accurate phenylketonuria (PKU) models.
• To assess the biochemical and behavioral adequacy of existing PKU models.
• To identify new trends and promising avenues for PKU research and treatment.

Main Methods:

• Detailed review of experimental progress in PKU model development over the past 15 years.
• Analysis of biochemical evidence on PKU pathophysiology in the context of model adequacy.
• Examination of emerging PKU research trends, including large neutral amino acids and novel experimental models.

Main Results:

• The emergence of models using combined phenylalanine (phe) and p-chlorophenylalanine (PCPA) administration represents a significant success.
• These phe-PCPA models provide a strong foundation for future research into PKU pathogenesis and treatment.
• New research trends include investigating large neutral amino acids and a novel model using alpha-methylphenylalanine (AMPhe) with phe.

Conclusions:

• The adoption of advanced phe-PCPA models is expected to improve biochemical investigations into PKU.
• PKU research is poised for a new era of productivity due to promising new models and research directions.
• Further utilization of existing models and exploration of new trends will advance the understanding and treatment of PKU.